Overview

Combined Donepezil and Selegiline Effects on Cocaine-Reinforced Behavior

Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
No medications are currently available for treatment of psychostimulant addiction, a compulsive preoccupation with use of cocaine and related compounds. Donepezil is a medication that is currently prescribed for Alzheimer's disease, and selegiline is a medication used for treatment of Parkinson's Disease. Both of these medications can decrease the amount of cocaine injections that laboratory animals choose to inject by vein. This project will determine if combined treatment with donepezil and selegiline can also decrease cocaine-motivated behavior for human subjects in a laboratory setting.
Phase:
Phase 2
Details
Lead Sponsor:
Midwest Biomedical Research Foundation
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Cocaine
Donepezil
Selegiline